PHARMEXA INC has a total of 34 patent applications. Its first patent ever was published in 1993. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are BN IMMUNOTHERAPEUTICS INC, STABILITECH LTD and MYCOMAGIC BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 11 | |
#2 | United States | 10 | |
#3 | Canada | 4 | |
#4 | Australia | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Japan | 2 | |
#7 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Machines | |
#5 | Computer technology | |
#6 | Measurement | |
#7 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Climate change adaptation technologies | |
#6 | Unspecified technologies | |
#7 | Animal care | |
#8 | Analysing materials | |
#9 | Bioinformatics |
# | Name | Total Patents |
---|---|---|
#1 | Sette Alessandro | 24 |
#2 | Newman Mark J | 15 |
#3 | Chesnut Robert | 12 |
#4 | Sidney John | 11 |
#5 | Celis Esteban | 11 |
#6 | Grey Howard M | 11 |
#7 | Southwood Scott | 11 |
#8 | Alexander Jeffery L | 8 |
#9 | Livingston Brian D | 6 |
#10 | Kubo Ralph T | 6 |
Publication | Filing date | Title |
---|---|---|
JP2010001303A | Hla-binding peptide and use thereof | |
US2009311283A1 | Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions | |
CA2658559A1 | Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions | |
WO2008054540A2 | Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions | |
WO2005120563A2 | Induction of an immune response against streptococcus pneumoniae polysaccharides | |
EP1732598A2 | Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions | |
US2005063983A1 | Inducing cellular immune responses to hepatitis B virus using peptide compositions | |
US7462354B2 | Method and system for optimizing minigenes and peptides encoded thereby | |
EP1842549A2 | Optimized minigenes and peptides encoded thereby | |
EP1230268A2 | Heteroclitic analogs of class i epitopes | |
EP0735893A1 | Pan dr-binding peptides for enhancement of the immune response |